The treatment of disseminated skin melanoma with high-dose recombinant interleukin-2 in combination with chemotherapy

被引：0
|
作者：
Streltsova, O. [1 ]
Baranau, Y. [1 ]
机构：
[1] Minsk City Clin Oncol Dispensary, Chemotherapy, Minsk, BELARUS
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
386P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The experience of administration of high-dose recombinant interleukin-2 in combination with chemotherapy in the management of disseminated skin melanoma
    Streltsova, Olga
    Baranau, Yauheni Valerievich
    Javrid, Edvard
    Barmotska, Maxim
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Experience in administration of high-dose interleukin-2 immunotherapy in combination with chemotherapy for disseminated skin melanoma management
    Baranau, Y.
    Zhavrid, E.
    Petrovitch, S.
    Sachivko, N.
    Zhuravkin, I.
    EJC SUPPLEMENTS, 2009, 7 (02): : 588 - 588
  • [3] High-dose recombinant interleukin-2/verapamil combination in advanced cancer
    Tagliaferri, P
    Correale, P
    Mottola, M
    deSimone, G
    Montesarchio, V
    Matano, E
    Rea, A
    Morabito, A
    Famiani, M
    Ciardiello, F
    Tortora, G
    Caraglia, M
    Barile, C
    Palmieri, G
    Bianco, AR
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1436 - 1437
  • [4] ERADICATION OF DISSEMINATED MURINE LEUKEMIA BY TREATMENT WITH HIGH-DOSE INTERLEUKIN-2
    THOMPSON, JA
    PEACE, DJ
    KLARNET, JP
    KERN, DE
    GREENBERG, PD
    CHEEVER, MA
    JOURNAL OF IMMUNOLOGY, 1986, 137 (11): : 3675 - 3680
  • [5] Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?
    Fishman, Julie
    Buchbinder, Elizabeth I.
    CANCER JOURNAL, 2024, 30 (02): : 120 - 125
  • [6] Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide
    Soni, S
    Lee, DS
    DiVito, J
    Bui, AH
    DeRaffele, G
    Radel, E
    Kaufman, HL
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (06) : 488 - 491
  • [7] High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
    Silk, Ann W.
    Kaufman, Howard L.
    Curti, Brendan
    Mehnert, Janice M.
    Margolin, Kim
    McDermott, David
    Clark, Joseph
    Newman, Jenna
    Bommareddy, Praveen K.
    Denzin, Lisa
    Najmi, Saltanat
    Haider, Azra
    Shih, Weichung
    Kane, Michael P.
    Zloza, Andrew
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [8] High-dose recombinant interleukin-2 produced in saccaromyces cerevisae ("RONCOLEUKIN") in patients with disseminated cutaneous melanoma: a phase 1 study
    Orlova, Rashida V.
    Moiseyenko, Vladimir V.
    Novik, Alexey V.
    Semenova, Anna I.
    Procenko, Svetlana A.
    Michailichenko, Tatyana D.
    Antimonik, Nina
    ANNALS OF ONCOLOGY, 2004, 15 : 204 - 204
  • [9] ROLE OF RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALFA AND CHEMOTHERAPY IN THE TREATMENT OF ADVANCED MELANOMA
    LEGHA, SS
    BUZAID, AC
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 27 - 32
  • [10] Interleukin-2 (ronkoleukin) in the managment of disseminated skin melanoma
    Baranau, Yauheni
    ANNALS OF ONCOLOGY, 2006, 17 : 167 - 168
12345